Degarelix: A New Approach for the Treatment of Prostate Cancer

Androgen deprivation therapy remains the mainstay of medical treatment for prostate cancer. Generally, this is achieved with medical androgen deprivation rather than orchidectomy, as most patients find the permanency and psychological effects of the latter unacceptable. Gonadotrophin-releasing hormo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuroendocrinology 2009-01, Vol.90 (3), p.235-244
Hauptverfasser:	Persson, Bo-Eric, Kold Olesen, Tine, Jensen, Jens-Kristian
Format:	Artikel
Sprache:	eng
Schlagworte:	At the Cutting Edge Clinical Trials as Topic Drug-Related Side Effects and Adverse Reactions Gonadotropin-Releasing Hormone - antagonists & inhibitors Humans Male Oligopeptides - adverse effects Oligopeptides - therapeutic use Prostatic Neoplasms - drug therapy Receptors, LHRH - antagonists & inhibitors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!